MIR6724-4

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR6724-4 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR6724-4 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR6724-4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6724-4 expression acts as an unfavorable survival marker.

SKCM, LUSC, and LUAD are the cancer types where MIR6724-4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMDFSTertileAll0.2520.737.04518view →
LUSCOSTertileAll0.0110.819<.00118view →
LUADOSTertileII,III,IV0.1500.677.00818view →
ESCAOSMedianIII,IV0.2990.517.01111view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR6724-4–SKCM (DFS)

Kaplan–Meier survival curve for MIR6724-4 RNA-high vs -low samples in SKCM.

Open the SKCM breakdown →

Exploration